July 28, 2026

Privia Health Group, Inc. (PRVA) Stock Analysis: Exploring a Potential 29% Upside with Solid Revenue Growth

Privia Health Group, Inc. (NASDAQ: PRVA) is making waves in the healthcare sector, especially in its niche of health information services. With a market capitalization of $3.11 billion, this Arlington,..

Arrowhead Pharmaceuticals (ARWR): Analyzing the Biotech Firm’s 20% Upside Potential Amidst Analyst Consensus

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) stands as a significant player in the biotechnology sector, focusing on developing innovative medicines for intractable diseases. With a market capitalization of $12.05 billion, this..

Protagonist Therapeutics, Inc. (PTGX) Stock Report: Exploring the Potential of a $8.72 Billion Biotech Innovator

Protagonist Therapeutics, Inc. (NASDAQ: PTGX), a prominent player in the biotechnology sector, is making waves with its promising pipeline of therapeutic candidates. With a market capitalization of $8.72 billion, this..

Surgery Partners, Inc. (SGRY) Stock Analysis: Unveiling a 22.85% Potential Upside in the Healthcare Sector

Surgery Partners, Inc. (NASDAQ: SGRY) is making waves in the healthcare sector, particularly within the medical care facilities industry. With a market capitalization of $1.98 billion, the company stands as..

Alvotech (ALVO) Stock Analysis: Exploring a Potential 111% Upside in the Biosimilar Market

Investors looking for opportunities in the healthcare sector may find Alvotech (NASDAQ: ALVO) an intriguing prospect. Specializing in the development and manufacturing of biosimilar medicines, Alvotech is positioned at the..

Zai Lab Limited (ZLAB) Stock Analysis: A Compelling 78.67% Potential Upside in Biotech Innovation

Zai Lab Limited (NASDAQ: ZLAB), a leading player in the biotechnology sector, offers a promising investment opportunity with a remarkable potential upside of 78.67%, according to analyst ratings. Despite the..

ACADIA Pharmaceuticals Inc. (ACAD) Stock Analysis: A 29% Upside Potential Amidst Promising Neurological Treatments

ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a pioneering biopharmaceutical company in the healthcare sector, is making waves with its focus on neurological and rare diseases. With a market capitalization of $4.35..

Drax extends the life of a key Scottish hydro asset

Drax has completed a £2 million refurbishment of Tongland Power Station as part of its wider programme to maintain and upgrade long-life renewable energy assets...

Biotech Growth Trust targets undervalued innovation

The Trust is focusing on undervalued biotech companies with strong clinical potential, takeover appeal and exposure to new medical innovation...

Unilever’s award-winning marketing supports its brand-led growth strategy

Unilever’s 2026 Cannes Lions campaigns show how the group is using consumer behaviour and local relevance to support its major brands...

Biotech Growth Trust notes $2.2 billion acquisition of Forte Biosciences

Argenx has agreed to acquire BIOG portfolio company Forte Biosciences for $77 per share in cash, representing a 40.5% premium. Forte accounted for 3.03% of the Company’s NAV at the..

Croda International reports 4.6% organic sales growth in first half of 2026

Croda International reported higher half-year sales, adjusted operating profit and free cash flow, while leaving its full-year 2026 outlook unchanged...

Man Group reports strong half-year growth in assets and profit

Man Group reported higher assets under management, stronger core revenue and profit, and continued growth in liquid credit and private credit...

Games Workshop Group Plc declares interim dividend of £1.40 per share

Games Workshop Group Plc has declared a dividend of £1.40 per share, with payment and election dates set out for shareholders...

Pantheon International reports June NAV increase and monthly portfolio activity

Pantheon International reported a 1.5% rise in June NAV per share, alongside share buybacks, new commitments and updated portfolio performance figures...

Tern increases Talking Medicines funding and raises shareholder distribution commitment

Tern has invested in additional Talking Medicines convertible loan notes and increased its minimum shareholder distribution commitment to 70% on qualifying exits...

Atalaya Mining Copper S.A. Atalaya Mining to release Q2 and H1 2026 financial results on 11 August

Atalaya Mining has said it will publish its unaudited Q2 2026 and H1 2026 financial results, with webcast and presentation details announced...

Ferrexpo reports Black Sea vessel incident and liquidity impact

Ferrexpo has updated investors on a Black Sea vessel incident, expected route disruption and a material negative impact on liquidity...

Alien Metals notes GreenTech quarterly update on Munni Munni and Whundo projects

Alien Metals notes GreenTech Metals’ quarterly update on drilling, resource work and exploration progress at Munni Munni and Whundo in Western Australia...

HILTON FOOD GROUP PLC ORD 10P (HFG.L)

⚠️ No article content returned.

..
Search

Funds

July 28, 2026

Drax extends the life of a key Scottish hydro asset

Drax has completed a £2 million refurbishment of Tongland Power Station as part of its wider programme to maintain and upgrade long-life renewable energy assets...

Biotech Growth Trust targets undervalued innovation

The Trust is focusing on undervalued biotech companies with strong clinical potential, takeover appeal and exposure to new medical innovation...

Unilever’s award-winning marketing supports its brand-led growth strategy

Unilever’s 2026 Cannes Lions campaigns show how the group is using consumer behaviour and local relevance to support its major brands...

Biotech Growth Trust notes $2.2 billion acquisition of Forte Biosciences

Argenx has agreed to acquire BIOG portfolio company Forte Biosciences for $77 per share in cash, representing a 40.5% premium. Forte accounted for 3.03% of the Company’s NAV at the time of the announcement...

Croda International reports 4.6% organic sales growth in first half of 2026

Croda International reported higher half-year sales, adjusted operating profit and free cash flow, while leaving its full-year 2026 outlook unchanged...

Man Group reports strong half-year growth in assets and profit

Man Group reported higher assets under management, stronger core revenue and profit, and continued growth in liquid credit and private credit...

Games Workshop Group Plc declares interim dividend of £1.40 per share

Games Workshop Group Plc has declared a dividend of £1.40 per share, with payment and election dates set out for shareholders...

Pantheon International reports June NAV increase and monthly portfolio activity

Pantheon International reported a 1.5% rise in June NAV per share, alongside share buybacks, new commitments and updated portfolio performance figures...

Tern increases Talking Medicines funding and raises shareholder distribution commitment

Tern has invested in additional Talking Medicines convertible loan notes and increased its minimum shareholder distribution commitment to 70% on qualifying exits...

Atalaya Mining Copper S.A. Atalaya Mining to release Q2 and H1 2026 financial results on 11 August

Atalaya Mining has said it will publish its unaudited Q2 2026 and H1 2026 financial results, with webcast and presentation details announced...

Ferrexpo reports Black Sea vessel incident and liquidity impact

Ferrexpo has updated investors on a Black Sea vessel incident, expected route disruption and a material negative impact on liquidity...

Alien Metals notes GreenTech quarterly update on Munni Munni and Whundo projects

Alien Metals notes GreenTech Metals’ quarterly update on drilling, resource work and exploration progress at Munni Munni and Whundo in Western Australia...
Search

Funds

July 28, 2026

FTSE 100

Funds